CXCR3 Antagonist Alleviates Autism-Like Behaviors and Neuroinflammation in BTBR Mice
Bioengineer.org
A CXCR3 antagonist significantly reduced autism-like behaviors and neuroinflammation in BTBR mice, a model for idiopathic autism spectrum disorder. The treatment improved social behaviors and reduced repetitive actions without causing sedation or affecting locomotion. The findings suggest that targeting CXCR3 signaling may offer a novel therapeutic approach for neuroimmune-related autism symptoms.
All articles from 13 November 2026. Summaries are AI-generated and may contain errors; the linked article is the authority.
Get this news by email
Daily or as a weekly roundup in your inbox. You confirm your address first; every email has an unsubscribe link. For another topic or language, use the subscribe page.